GALECTIN THERAPEUTICS INC
For the period ended Sep 30, 2025. Filed Nov 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Other Information
Securities Trading Plans of Directors and Executive Officers
One of our executive officers of the Company, as defined in Rule 16a-1(f), adopted a replacement “Rule 10b5-1 trading arrangement”, as defined in Regulation S-K Item 408, during the fiscal quarter ended September 30, 2025.
Item 6.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.